pre-IPO PHARMA

COMPANY OVERVIEW

Centessa Pharmaceuticals Limited is a next-generation biopharmaceutical company that aims to reshape the traditional drug development process. The company applies an asset-centric R&D model at scale to advance a portfolio of highly validated programs led by industry leading teams. Each program is developed by an Centessa Subsidiary and supported by a centralized infrastructure and the Centessa management team. The company is headquartered in Cambridge, Mass.


LOCATION

  • Cambridge, MA, USA

  • THERAPEUTIC AREAS

  • Hematology
  • Immunology
  • Inflammatory Disease
  • Neurological DIsorders
  • Oncology
  • Rare Diseases

  • WEBSITE

    https://www.centessa.com/index.html


    CAREER WEBSITE

    None


    SOCIAL MEDIA


    INVESTORS

    boxer-capital bvf-partners cormorant-asset-management ecor1-capital franklin-templeton general-atlantic janis-henderson-investors lifesci-venture-partners logos-capital medicxi samsara-biocapital t-rowe-price venrock vida-ventures wellington-management

    PRESS RELEASES


    Jun 7, 2021

    Citi Appointed as Depositary Bank for Centessa Pharmaceuticals plc’s ADR Programme


    May 17, 2021

    Centessa Pharmaceuticals Announces Expansion of Management Team and Board of Directors


    May 10, 2021

    Centessa Pharmaceuticals Appoints One of the World’s Leading Drug Developers, Antoine Yver, M.D., M.Sc., as Chief Medical Officer


    Mar 25, 2021

    Centessa Pharmaceuticals Announces Departure of Dr. Moncef Slaoui


    Mar 11, 2021

    Centessa Pharmaceuticals Appoints Gregory Weinhoff, M.D., MBA, as Chief Financial Officer and Expands Board of Directors


    For More Press Releases


    Google Analytics Alternative